Lukas Shumway
Stock Analyst at Barclays
(2.55)
# 3,009
Out of 4,630 analysts
10
Total ratings
66.7%
Success rate
8.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lukas Shumway
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLLS Cellectis | Maintained: Buy | $9 | $2.84 | +217.46% | 1 | Aug 7, 2026 | |
| DRTS Alpha Tau Medical | Maintained: Buy | $17 | $13.14 | +29.38% | 4 | Jul 14, 2026 | |
| IMNM Immunome | Maintained: Buy | $36 | $25.03 | +43.83% | 3 | Jul 9, 2026 | |
| STRO Sutro Biopharma | Maintained: Buy | $56 | $25.38 | +120.65% | 2 | Jun 23, 2026 |
Cellectis
Aug 7, 2026
Maintained: Buy
Price Target: $9
Current: $2.84
Upside: +217.46%
Alpha Tau Medical
Jul 14, 2026
Maintained: Buy
Price Target: $17
Current: $13.14
Upside: +29.38%
Immunome
Jul 9, 2026
Maintained: Buy
Price Target: $36
Current: $25.03
Upside: +43.83%
Sutro Biopharma
Jun 23, 2026
Maintained: Buy
Price Target: $56
Current: $25.38
Upside: +120.65%